Cargando…
Brain Leukocytes as the Potential Therapeutic Target for Post-COVID-19 Brain Fog
After recovering from the acute phase of coronavirus disease 2019 (COVID-19), many patients struggle with additional symptoms of long COVID during the chronic phase. Among them, the neuropsychiatric manifestations characterized by a short-term memory loss and inability to concentrate are called “bra...
| Autor principal: | |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Springer US
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10034247/ https://www.ncbi.nlm.nih.gov/pubmed/36952147 http://dx.doi.org/10.1007/s11064-023-03912-0 |